ClinicalTrials.gg
RecruitingNCT07648680VIMEC-ICUpdated Jun 15, 2026

"Menopause Experiences in Cultural and Intercultural Contexts"

An observational study in Valid MeSH Conditions, sponsored by Institut Investigacio Sanitaria Pere Virgili. Recruiting at 1 site in Spain. Open to female participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Institut Investigacio Sanitaria Pere Virgili · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
25
Ages
40 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 597 studies in Motor Activity with a site in Spain — 148 open to participants now, 184 under way, 1 of them phase 3. Motor Activity · Spain.

Planned enrollment
54th of 58
25 · median 145
Started
2026
with 65 others
Observational
58 of 597
22 open now
Primary completion
2028-04
later than 170 of 183 live
Registered
563rd of 597
by date

Among the 597 studies in Motor Activity with a site in Spain, this one is the 54th largest by planned enrollment of the 58 observational ones that give a count, is one of 66 that started in 2026, is one of 58 observational ones, reaches primary completion later than 170 of the 183 other live ones, and was the 563rd registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

148 of the 597 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:

142 more — sign in →

All 148 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 40 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 597 studies in Motor Activity with a site in Spain, or all of them as a file.
02

Study summary

The climacteric period involves physical, hormonal, and emotional changes that can impact a woman's quality of life. This mixed-methods study aims to explore the perceptions and experiences of women during menopause and the influence of cultural ethnicity on their quality of life in Primary Care centers in Tarragona. The research includes a quantitative phase to assess healthcare professionals' knowledge via electronic surveys and a qualitative phase using individual interviews with women from diverse backgrounds. The goal is to identify specific needs to adapt community nursing interventions and improve health promotion and equity during the climacteric stage.

Read the detailed description

This study employs a mixed-methods approach to provide a comprehensive understanding of the climacteric process in the health area of Tarragona. The research is divided into two distinct but complementary phases:

  1. Quantitative Phase (Cross-sectional Descriptive Study):

    The objective is to evaluate the level of knowledge and the attitudes of healthcare professionals (nurses and physicians) regarding menopause management.

    Data Collection: An ad hoc questionnaire will be distributed electronically through the corporate email systems of the Primary Care centers (ICS).

    Variables: Sociodemographic data, professional profile, and specific knowledge scores on menopause, Mediterranean diet, and physical activity recommendations.

    Analysis: Descriptive and inferential statistics will be performed using IBM SPSS Statistics.

  2. Qualitative Phase (Phenomenological Approach):

The objective is to explore the lived experiences, perceptions, and cultural influences of women in the climacteric stage.

Data Collection: Semi-structured individual interviews will be conducted with women from diverse sociocultural and ethnic backgrounds to ensure maximum variation.

Sampling: Purposeful sampling will be used until data saturation is reached.

Analysis: All interviews will be transcribed verbatim and analyzed using thematic analysis with the support of Atlas.ti software.

Ethics and Integration:

The study follows the Declaration of Helsinki and has been approved by the Ethics Committee (IDIAP Jordi Gol). Data from both phases will be integrated to identify specific gaps in clinical practice and the real-world needs of women, aiming to design better community nursing interventions.

03

Conditions studied

  • Valid MeSH Conditions

Browse trials for

Keywords

  • Menopause
  • quality of life
  • physical activity
  • Mediterranean Diet
  • Nursing
04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of two main groups located in the Tarragona healthcare area:

Healthcare Professionals: Nurses and physicians working in Primary Care centers (Institut Català de la Salut) who provide care to women during the climacteric stage.

Women in the Climacteric Stage: Women aged 40 to 65 years from diverse sociocultural and ethnic backgrounds who are users of the Primary Care centers in the same geographical area.

The sample will be drawn from urban and rural health centers to ensure a representative professional perspective and a diverse range of lived experiences from the women interviewed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For professionals:

  • Healthcare professional aged 18 years or older.
  • Currently working in the Primary Care setting.
  • Provide care or work with women in the climateric stage.
  • Agreement to participate and completion of the anonymous survey after providing .

For Women (Qualitative Phase):

  • Women aged 40 to 65 years.
  • Currently in the climacteric stage (perimenopause or ).
  • Belonging to diverse sociocultural or ethnic backgrounds.
  • Ability to communicate and provide informed consent for the individual interview.

Exclusion criteria

Exclusion Criteria:

For porfessionals:

*Refusal to participate in the study or incomplete electronic survey.

For Women (Qualitative Phase):

  • Inability to understand the study's language (Spanish or Catalan).
  • Cognitive impairment that prevents the participant from providing or participating in the interview/survey.
  • Refusal to participate in the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
25 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthcare Professionals

    Primary care nurses and physicians working in the health centers of Tarragona (ICS). This group will participate in the quantitative phase by completing an online survey about their knowledge and attitudes toward menopause.

    Behavioral: Survey and Semi-structured Interview

  • Women in Climacteric Stage

    Women aged between 40 and 65 years from diverse sociocultural and ethnic backgrounds. This group will participate in the qualitative phase through individual semi-structured interviews to explore their experiences and quality of life.

    Behavioral: Survey and Semi-structured Interview

Interventions

  • BehavioralSurvey and Semi-structured Interview

    For Professionals: An electronic questionnaire to assess knowledge and attitudes toward menopause. For Women: A qualitative semi-structured interview to explore their perceptions and lived experiences during the climacteric stage.

06

What researchers measure

Primary outcomes

  1. Perceptions and Lived Experiences of Women in the Climacteric Stage.

    Exploration of the subjective experiences, cultural influences, and quality of life through thematic analysis of semi-structured interviews.

    Time frame: Baseline.

  2. Level of Knowledge and Attitudes of Healthcare Professionals Regarding Menopause.

    Evaluation of knowledge scores and professional attitudes towards menopause management through an ad hoc electronic questionnaire. The questionnaire provides a total score ranging from 0 to10, where 0 indicates the lowest level of knowledge and poorest attitude, and 10 indicates the highest level of knowledge and most positive attitude towards menopause management.

    Time frame: Baseline at the time of survey completion.

07

Study locations

1 of 1 sites recruiting
  • Institut Català de la Salut (ICS) - Camp de Tarragona.
    Tarragona, Spain
    Recruiting
    • Rocío Legaz Pagán, RN, BcS, PhD Student · Contactrlegazpagan39@gmail.com · 646057662
    • Marina Gómez de Quero Cordoba, RN, MSN, PhD · Contactmarina.gomezdequero@urv.cat
    • Rocío Legaz Pagán, RN, BcS, PhD Student · Principal investigator
    • Marina Gómez de Quero Cordoba, RN, MSN, PhD · Sub investigator
    • Rosa Raventós Torner, RN, MSN, PhD · Sub investigator
    • Cristina Rey Reñones, RN, MSN, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — "Individual participant data will not be shared to protect the confidentiality and anonymity of the participants, in accordance with the informed consent and Spanish data protection laws (LOPDGDD 3/2018)."

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2026 (actual). Primary completion is estimated for Apr 2028, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2026
First posted
Jun 15, 2026
StartActual
Apr 27, 2026
Primary completionEst.
Apr 22, 2028
CompletionEst.
Apr 22, 2030
Last update
Jun 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07648680
Lead sponsor
Institut Investigacio Sanitaria Pere Virgili
Responsible party
Sponsor
First posted
Jun 15, 2026
Start date
Apr 27, 2026
Primary completion
Apr 22, 2028 (estimated)
Completion
Apr 22, 2030 (estimated)
Last update
Jun 15, 2026

Study contacts

Rocío Legaz Pagán, PhD Student, RN, BcS
Contact
rlegazpagan39@gmail.com
+34646057662 ext. 0034
Marina Gómez de Quero Cordoba, RN, MSN, PhD
Contact
marina.gomezdequero@urv.cat
Rosa Raventós Torner, RN, MSN, PhD
study chair · Universidad Rovira i Virgili
Cristina Rey Reñones, RN, MSN, PhD
study director · Universidad Rovira Y Virgili
Rocío Legaz Pagán, PhD Student, RN, MSc
principal investigator · Universidad Rovira Y Virgili
Marina Gómez de Quero Cordoba, RN, MSN, PhD
study director · Universidad Rovira Y Virgili

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion